Condition
Prosthetic Valve Endocarditis
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Not Yet Recruiting1
Unknown1
Terminated1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07885761Not Yet Recruiting
REVIVE-FR Registry
NCT07253688Phase 3Terminated
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
NCT05989152Not ApplicableRecruitingPrimary
Evolution of PET Fixation With FDG at the End of Antibiotic Treatment of Infective Endocarditis on Valvular Prosthesis
NCT05455788UnknownPrimary
Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
Showing all 4 trials